These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 24008021)

  • 1. Early discontinuation of treatment in patients with orthostatic hypotension.
    Shibao C; Grijalva CG; Lipsitz LA; Biaggioni I; Griffin MR
    Auton Neurosci; 2013 Oct; 177(2):291-6. PubMed ID: 24008021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fludrocortisone Is Associated With a Higher Risk of All-Cause Hospitalizations Compared With Midodrine in Patients With Orthostatic Hypotension.
    Grijalva CG; Biaggioni I; Griffin MR; Shibao CA
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29025750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of atomoxetine versus midodrine for the treatment of orthostatic hypotension in autonomic failure.
    Ramirez CE; Okamoto LE; Arnold AC; Gamboa A; Diedrich A; Choi L; Raj SR; Robertson D; Biaggioni I; Shibao CA
    Hypertension; 2014 Dec; 64(6):1235-40. PubMed ID: 25185131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of single or combined midodrine and pyridostigmine in orthostatic hypotension.
    Byun JI; Moon J; Kim DY; Shin H; Sunwoo JS; Lim JA; Kim TJ; Lee WJ; Lee HS; Jun JS; Park KI; Lee ST; Jung KH; Jung KY; Lee SK; Chu K
    Neurology; 2017 Sep; 89(10):1078-1086. PubMed ID: 28794253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of orthostatic hypotension due to autonomic failure with a peripheral alpha-adrenergic agonist (midodrine).
    Kaufmann H; Brannan T; Krakoff L; Yahr MD; Mandeli J
    Neurology; 1988 Jun; 38(6):951-6. PubMed ID: 2452997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-world droxidopa or midodrine treatment persistence in patients with neurogenic orthostatic hypotension or orthostatic hypotension.
    Kymes SM; Sullivan C; Jackson K; Raj SR
    Auton Neurosci; 2020 May; 225():102659. PubMed ID: 32200263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary experience with midodrine in kidney/pancreas transplant patients with orthostatic hypotension.
    Hurst GC; Somerville KT; Alloway RR; Gaber AO; Stratta RJ
    Clin Transplant; 2000 Feb; 14(1):42-7. PubMed ID: 10693634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new hope in the nightmare of diabetic orthostatic hypotension: the midodrine-fludrocortisone association.
    Andreelli F; Plotton I; Thivolet C; Riou JP
    Diabetes Obes Metab; 1999 Sep; 1(5):297-8. PubMed ID: 11225642
    [No Abstract]   [Full Text] [Related]  

  • 9. Midodrine. A review of its therapeutic use in the management of orthostatic hypotension.
    McClellan KJ; Wiseman LR; Wilde MI
    Drugs Aging; 1998 Jan; 12(1):76-86. PubMed ID: 9467688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of atomoxetine versus midodrine for neurogenic orthostatic hypotension.
    Byun JI; Kim DY; Moon J; Shin HR; Sunwoo JS; Lee WJ; Lee HS; Park KI; Lee ST; Jung KH; Jung KY; Kim M; Lee SK; Chu K
    Ann Clin Transl Neurol; 2020 Jan; 7(1):112-120. PubMed ID: 31856425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adding droxidopa to fludrocortisone or midodrine in a patient with neurogenic orthostatic hypotension and Parkinson disease.
    Kremens D; Lew M; Claassen D; Goodman BP
    Clin Auton Res; 2017 Jul; 27(Suppl 1):29-31. PubMed ID: 28674867
    [No Abstract]   [Full Text] [Related]  

  • 12. Midodrine hydrochloride and the treatment of orthostatic hypotension in tetraplegia: two cases and a review of the literature.
    Barber DB; Rogers SJ; Fredrickson MD; Able AC
    Spinal Cord; 2000 Feb; 38(2):109-11. PubMed ID: 10762185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral Midodrine Hydrochloride for Prevention of Orthostatic Hypotension during Early Mobilization after Hip Arthroplasty: A Randomized, Double-blind, Placebo-controlled Trial.
    Jans Ø; Mehlsen J; Kjærsgaard-Andersen P; Husted H; Solgaard S; Josiassen J; Lunn TH; Kehlet H
    Anesthesiology; 2015 Dec; 123(6):1292-300. PubMed ID: 26492477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological options in the management of orthostatic hypotension in older adults.
    Kearney F; Moore A
    Expert Rev Cardiovasc Ther; 2009 Nov; 7(11):1395-400. PubMed ID: 19900022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New Horizons in orthostatic hypotension.
    Frith J; Parry SW
    Age Ageing; 2017 Mar; 46(2):168-174. PubMed ID: 27864240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Treatment of Primary Orthostatic Hypotension.
    Hale GM; Valdes J; Brenner M
    Ann Pharmacother; 2017 May; 51(5):417-428. PubMed ID: 28092986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, double-blind multicenter study. Midodrine Study Group.
    Low PA; Gilden JL; Freeman R; Sheng KN; McElligott MA
    JAMA; 1997 Apr; 277(13):1046-51. PubMed ID: 9091692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orthostatic hypotension associated with baroreceptor dysfunction: treatment approaches.
    Briasoulis A; Silver A; Yano Y; Bakris GL
    J Clin Hypertens (Greenwich); 2014 Feb; 16(2):141-8. PubMed ID: 24588814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Midodrine as adjunctive support for treatment of refractory hypotension in the intensive care unit: a multicenter, randomized, placebo controlled trial (the MIDAS trial).
    Anstey MH; Wibrow B; Thevathasan T; Roberts B; Chhangani K; Ng PY; Levine A; DiBiasio A; Sarge T; Eikermann M
    BMC Anesthesiol; 2017 Mar; 17(1):47. PubMed ID: 28327122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orthostatic hypotension: A review.
    Joseph A; Wanono R; Flamant M; Vidal-Petiot E
    Nephrol Ther; 2017 Apr; 13 Suppl 1():S55-S67. PubMed ID: 28577744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.